17551159

Source:http://linkedlifedata.com/resource/pubmed/id/17551159

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0220825, umls-concept:C0289313, umls-concept:C0936012, umls-concept:C2827738
pubmed:issue	1
pubmed:dateCreated	2007-7-5
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00379769
pubmed:abstractText	A recent meta-analysis raised concern regarding an increased risk of myocardial infarction and death from cardiovascular causes associated with rosiglitazone treatment of type 2 diabetes.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-17551160, http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-17551161, http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-17551162, http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-17975869, http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-18022724, http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-18063730, http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-18625116, http://linkedlifedata.com/resource/pubmed/commentcorrection/17551159-20647188
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Metformin, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1533-4406
pubmed:author	pubmed-author:Beck-NielsenHenningH, pubmed-author:GomisRamónR, pubmed-author:HanefeldMarkolfM, pubmed-author:HomePhilip DPD, pubmed-author:JonesNigel PNP, pubmed-author:KomajdaMichelM, pubmed-author:McMurrayJohn J VJJ, pubmed-author:PocockStuart JSJ, pubmed-author:RECORD Study Group
pubmed:copyrightInfo	Copyright 2007 Massachusetts Medical Society.
pubmed:issnType	Electronic
pubmed:day	5
pubmed:volume	357
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	28-38
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:17551159-Adult, pubmed-meshheading:17551159-Aged, pubmed-meshheading:17551159-Cardiovascular Diseases, pubmed-meshheading:17551159-Diabetes Mellitus, Type 2, pubmed-meshheading:17551159-Drug Therapy, Combination, pubmed-meshheading:17551159-Female, pubmed-meshheading:17551159-Follow-Up Studies, pubmed-meshheading:17551159-Heart Failure, pubmed-meshheading:17551159-Hospitalization, pubmed-meshheading:17551159-Humans, pubmed-meshheading:17551159-Hypoglycemic Agents, pubmed-meshheading:17551159-Kaplan-Meier Estimate, pubmed-meshheading:17551159-Male, pubmed-meshheading:17551159-Metformin, pubmed-meshheading:17551159-Middle Aged, pubmed-meshheading:17551159-Myocardial Infarction, pubmed-meshheading:17551159-Risk, pubmed-meshheading:17551159-Sulfonylurea Compounds, pubmed-meshheading:17551159-Thiazolidinediones
pubmed:year	2007
pubmed:articleTitle	Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
pubmed:affiliation	Newcastle Diabetes Centre and Newcastle University, Newcastle upon Tyne, United Kingdom. philip.home@newcastle.ac.uk
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study